Filing Details
- Accession Number:
- 0001104659-18-019364
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-21 17:16:20
- Reporting Period:
- 2018-03-19
- Accepted Time:
- 2018-03-21 17:16:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1660719 | Aralez Pharmaceuticals Inc. | ARLZ | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1527710 | Patrick James Tursi | C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, Without Par Value | Disposition | 2018-03-19 | 5,950 | $1.70 | 251,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018.